Open access · CC-BY
via OpenAlex
Blueberry Supplementation in Midlife for Dementia Risk Reduction
Robert Krikorian, Matthew R. Skelton, Suzanne Summer, Marcelle D. Shidler, Patrick G. Sullivan
Nutrients · 2022 · ▲ 69 citations
Abstract
Late-life dementia typically develops over a period of many years beginning in midlife. Prevalence of metabolic disturbance also accelerates in middle age and is a prominent risk factor for dementia. Preliminary studies indicate that blueberry supplementation can improve cognitive performance and influence metabolism and brain function and therefore may have a role in early intervention to prevent neurodegeneration. In a randomized controlled trial, we investigated the effects of daily blueberry supplementation in a middle-aged sample of insulin-resistant participants with elevated risk for future dementia. We enrolled overweight men and women, aged 50 to 65 years, with subjective cognitive decline (SCD) and performed pre- and post-intervention assessments of cognition and metabolism and exploratory measures of peripheral mitochondrial function. We observed improved performances for the blueberry group on measures of lexical access, p = 0.003, and memory interference, p = 0.04, and blueberry-treated participants reported reduced memory encoding difficulty in daily life activities, p = 0.03. The blueberry-treated group also exhibited correction of peripheral hyperinsulinemia, p = 0.04, and a modest trend for increased mitochondrial uncoupling, p = 0.11. The cognitive findings indicated improved executive ability in this middle-aged sample. In addition, the changes in metabolic and bioenergetic measures imply potential mechanistic factors associated with anthocyanin and proanthocyanidin actions. The demonstration of these benefits in middle-aged individuals with insulin resistance and SCD suggests that ongoing blueberry supplementation may contribute to protection against cognitive decline when implemented early in at-risk individuals.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/nu14081619
- Canonical
- link ↗
- Fetched
- 2026-07-24 MST
Cite this
APA
Krikorian, R., Skelton, M.R., Summer, S., Shidler, M.D., & Sullivan, P.G. (2022). Blueberry Supplementation in Midlife for Dementia Risk Reduction. <em>Nutrients</em>. https://doi.org/10.3390/nu14081619
Vancouver
Krikorian R, Skelton MR, Summer S, Shidler MD, Sullivan PG. Blueberry Supplementation in Midlife for Dementia Risk Reduction. Nutrients. 2022. doi:10.3390/nu14081619.
BibTeX
@article{robert2022Bluebe,
title = {Blueberry Supplementation in Midlife for Dementia Risk Reduction},
author = {Robert Krikorian and Matthew R. Skelton and Suzanne Summer and Marcelle D. Shidler and Patrick G. Sullivan},
journal = {Nutrients},
year = {2022},
doi = {10.3390/nu14081619},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Stanford University 2003
Open access · US-GOV
Estrogen Use in Protection From Cognitive Decline
University of Manitoba 2018
Open access · US-GOV
Brain Fitness APP for Aging With a Healthy Brain and Detecting Cognitive Declines
Fondazione Golgi Cenci 2011
Open access · US-GOV
Effects of Cognitive Stimulation in Elderly Individuals at Risk to Develop Dementia: a Randomized Controlled Trial (Allena-Mente).
Rejuvenation Research 2026
Citation only
Impact of Metformin on Healthspan-Related Outcomes and Incidence of Diseases of Aging in People with Type 2 Diabetes Mellitus: A Systematic Review
Rejuvenation research 2026
Citation only
Impact of Metformin on Healthspan-Related Outcomes and Incidence of Diseases of Aging in People with Type 2 Diabetes Mellitus: A Systematic Review.
Neurobehavioral Systems, Inc. 2021
Open access · US-GOV